MYRX Stock Chart & Stats
$0.01
$0.00(0.00%)
At close: 4:00 PM EST
$0.01
$0.00(0.00%)
Day’s Range― - ―
52-Week Range― - ―
Previous CloseN/A
Volume1.89K
Average Volume (3M)N/A
Market Cap
$27.58K
Enterprise ValueN/A
Total Cash (Recent Filing)N/A
Total Debt (Recent Filing)N/A
Price to Earnings (P/E)―
Beta-2.01
Next EarningsN/A
EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)N/A
Shares Outstanding34,479,000
10 Day Avg. VolumeN/A
30 Day Avg. VolumeN/A
Financial Highlights & Ratios
PEG RatioN/A
Price to Book (P/B)0.00
Price to Sales (P/S)0.00
P/FCF Ratio0.00
Enterprise Value/Market Cap0.00
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
EPS Forecast (FY)N/A
Revenue Forecast (FY)N/A
MYRX FAQ
What was Myrexis Inc’s price range in the past 12 months?
Currently, no data Available
What is Myrexis Inc’s market cap?
Myrexis Inc’s market cap is $27.58K.
When is Myrexis Inc’s upcoming earnings report date?
The company’s upcoming earnings report date is not yet available.
How were Myrexis Inc’s earnings last quarter?
Currently, no data Available
Is Myrexis Inc overvalued?
According to Wall Street analysts Myrexis Inc’s price is currently Overvalued.
Does Myrexis Inc pay dividends?
Myrexis Inc pays a Notavailable dividend of $2.86 which represents an annual dividend yield of N/A. See more information on Myrexis Inc dividends here
What is Myrexis Inc’s EPS estimate?
Myrexis Inc’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Myrexis Inc have?
Myrexis Inc has 34,479,000 shares outstanding.
What happened to Myrexis Inc’s price movement after its last earnings report?
Currently, no data Available
Which hedge fund is a major shareholder of Myrexis Inc?
Currently, no hedge funds are holding shares in MYRX
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Company Description
Myrexis Inc
Myrexis, Inc. dedicates its efforts to identifying, evaluating, and financially backing ventures within the life sciences sector. The company, which now operates under the name Myrexis, Inc., was previously known as Myriad Pharmaceuticals, Inc. until its rebranding took place in July 2010. Its main corporate offices are situated in New York, New York.
―
XChange TECINC
―
Lion Group Holding
―
Pineapple Financial
―
CN Healthy Food Tech Group
―
Ownership Overview
―
Insiders
1.26% Mutual Funds
<0.01% Other Institutional Investors
98.74% Public Companies and
Individual Investors
Options Prices
Currently, No data available
---